Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis

PLoS One. 2016 Aug 26;11(8):e0161908. doi: 10.1371/journal.pone.0161908. eCollection 2016.

Abstract

Background: Patients with idiopathic interstitial pneumonias sometimes have a few features of connective tissue disease (CTD) and yet do not fulfil the diagnostic criteria for any specific CTD.

Objective: This study was conducted to elucidate the characteristics, prognosis, and disease behavior in patients with interstitial lung disease (ILD) associated with systemic sclerosis (SSc)-related autoantibodies.

Methods: We retrospectively analyzed medical records of 72 ILD patients: 40 patients with SSc (SSc-ILD) and 32 patients with SSc-related autoantibody-positive ILD but not with CTD (ScAb-ILD), indicating lung-dominant CTD with SSc-related autoantibody.

Results: Patients with SSc-ILD were predominantly females and non-smokers, and most had nonspecific interstitial pneumonia confirmed by high-resolution computed tomography (HRCT) and pathological analysis. However, about half of the patients with ScAb-ILD were male and current or ex-smokers. On HRCT analysis, honeycombing was more predominant in patients with ScAb-ILD than with SSc-ILD. Pathological analysis showed the severity of vascular intimal or medial thickening in the SSc-ILD patients to be significantly higher than that in the ScAb-ILD patients. Survival curves showed that the patients with ScAb-ILD had a significantly poorer outcome than those with SSc-ILD.

Conclusion: Data from this study suggest that lung-dominant CTD with SSc-related autoantibody is a different disease entity from SSc-ILD.

MeSH terms

  • Aged
  • Autoantibodies / immunology*
  • Female
  • Humans
  • Idiopathic Interstitial Pneumonias / immunology*
  • Idiopathic Interstitial Pneumonias / physiopathology*
  • Idiopathic Pulmonary Fibrosis / immunology
  • Idiopathic Pulmonary Fibrosis / physiopathology
  • Kaplan-Meier Estimate
  • Lung Diseases, Interstitial / immunology*
  • Lung Diseases, Interstitial / physiopathology*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Scleroderma, Systemic / immunology
  • Scleroderma, Systemic / physiopathology
  • Vital Capacity / physiology

Substances

  • Autoantibodies

Grants and funding

The authors received no specific funding for this work.